# A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times

> **NCT04513704** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 156 (actual)

## Conditions studied

- Healthy Volunteers Type 2 Diabetes

## Interventions

- **DRUG:** Oral Semaglutide

## Key facts

- **NCT ID:** NCT04513704
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-28
- **Primary completion:** 2021-04-20
- **Final completion:** 2021-05-26
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2023-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04513704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04513704, "A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04513704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*